Pharmaceuticals, Biotechnology and Life Sciences
Experienced CEO brings expertise in product development, cell and gene therapies, and public biotechnology companies as Obsidian positions itself for…
Experienced CEO brings expertise in product development, cell and gene therapies, and public biotechnology companies as Obsidian positions itself for…
Designation based on positive primary analysis of pivotal study, N-MOmentum GAITHERSBURG, Md.–(BUSINESS WIRE)–Viela Bio today announced that the U.S. Food…
– FCR001 established durable immune tolerance in 70% of patients – Results support initiation of Phase 3 registration study later…
FORT WORTH, Texas–(BUSINESS WIRE)–Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished…
– Financing will support Phase 3 trial of FCR001 for living donor kidney transplant patients and additional Phase 2 studies…
DUBLIN–(BUSINESS WIRE)–The “Phenylketonuria (PKU) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly…
Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult…
PANGYO, South Korea & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and…